Skip to content

Medical-device intelligence

JWY: Manual Antimicrobial Susceptibility Test Systems

FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JWY
FDA device name
Manual Antimicrobial Susceptibility Test Systems
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202620
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JWY · Manual Antimicrobial Susceptibility Test Systems44178

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

519 matching records
Device / recordCompany in FDA recordSourceSource date
Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dalbavancin in the dilution ra…K231988 · JWYThermo Fisher Scientific510(k)Aug 30, 2023FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Sulbactam-durlobactam in the dilution range of 0.015/4-32/4 ug/mLK231994 · JWYThermo Fisher Scientific510(k)Aug 25, 2023FDA decision date
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC, or Breakpoint Susceptibility System with Imipenem-relebactam in the di…K230935 · JWYThermo Fisher Scientific510(k)Jun 30, 2023FDA decision date
ComASP Cefiderocol 0.008-128K230479 · JWYLiofilchem s.r.l.510(k)May 18, 2023FDA decision date
Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution r…K223844 · JWYThermo Fisher Scientific510(k)Mar 21, 2023FDA decision date
ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218Z-0817-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412240Z-0818-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412252Z-0819-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL BENZYLPENICIL PG 256 US S30, CATALOG 412262Z-0820-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL CEFTRIAXONE TX 32 US S30, CATALOG 412302Z-0821-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL ERTAPENEM ETP 32 US S30, CATALOG 412331Z-0822-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL ERYTHROMYCIN EM 256 US S30, CATALOG 412333Z-0823-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL IMIPENEM IP 32 US S30, CATALOG 412373Z-0825-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL LEVOFLOXACIN LE 32 US S30, CATALOG 412392Z-0826-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL MEROPENEM MP 32 US S30, CATALOG 412401Z-0827-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL MINOCYCLINE MC 256 US S30, CATALOG 412407Z-0828-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL RIFAMPICIN RI 32 US S30, CATALOG 412449Z-0829-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL TOBRAMYCIN TM 256 US S30, CATALOG 412478Z-0830-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL VANCOMYCIN VA 256 US S30, CATALOG 412486Z-0831-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL CEFTOLOZANE/TAZO C/T US S30, CATALOG 414445Z-0841-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL CEFTAZIDIM/AVIBACTAM US S30, CATALOG 419046Z-0846-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927Z-0849-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL ERAVACYCLINE ERV US S30, CATALOG 421553Z-0851-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL ETEST MEROPENEM/VABORBACTAM MEV US S30, CATALOG 421560Z-0852-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
ETEST CLINICAL ETEST MEROPENEM MP M100 US, CATALOG 423786Z-0859-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗